C12Y 207/01145
Deoxynucleoside kinase
Official title: Deoxynucleoside kinase (2.7.1.145)
C12Y207/01145 (Deoxynucleoside kinase) appears on 3 US grants and 3 published applications in this corpus.
Search patents in C12Y- Granted patents
- 3
- Published applications
- 3
- Assignees
- 1
- Inventors
- 1
- Latest grant
- 9 Jun 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 1 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
| 2019 | 0 | 1 |
| 2020 | 1 | 0 |
By publication year.
Recent patents
- Multimodal trail molecules expressed in T cells9 Jun 2020US 10,676,515 B2The General Hospital Corporation
- Biodegradable matrix comprising stem cells that express soluble TRAIL24 Jul 2018US 10,030,057 B2The General Hospital Corporation
- Treatment and bioluminescent visualization using multimodal TRAIL molecules30 Aug 2016US 9,428,565 B2The General Hospital Corporation
- Multimodal trail molecules and uses in cellular therapies17 Jan 2019US 2019/0016767 A1The General Hospital Corporation
- Multimodal trail molecules and uses in cellular therapies17 Nov 2016US 2016/0333064 A1The General Hospital Corporation
- Multimodal trail molecules and uses in cellular therapies27 Mar 2014US 2014/0086907 A1The General Hospital Corporation
Most cited
By later US patents